Form 8-K - Current report:
SEC Accession No. 0001193125-25-159942
Filing Date
2025-07-16
Accepted
2025-07-16 17:07:29
Documents
14
Period of Report
2025-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944012d8k.htm   iXBRL 8-K 32735
2 EX-99.1 d944012dex991.htm EX-99.1 14021
6 GRAPHIC g944012g0716210830553.jpg GRAPHIC 3284
  Complete submission text file 0001193125-25-159942.txt   176263

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20250715.xsd EX-101.SCH 2511
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20250715_lab.xml EX-101.LAB 18665
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20250715_pre.xml EX-101.PRE 11672
16 EXTRACTED XBRL INSTANCE DOCUMENT d944012d8k_htm.xml XML 3906
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 251128036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)